pemigatinib
innovent biologics,incyte
['pemazyre', 'pemigatinib', 'innovent', '$ivbiy']
$ivbiy innovent announces overall survival results of phase 2 study of pemazyre (pemigatinib) in chinese patients with advanced cholangiocarcinoma presented at aacr annual meeting 2023 